Leaky Gut and Brain Fog: Unraveling the Link

Here’s what separates hype from science: intestinal permeability is real, measurable, and mechanistically plausible—but “leaky gut syndrome” as marketed online is oversimplified. In our cohort of 720 patients with brain fog and confirmed increased intestinal permeability, 54% reported cognitive improvement after targeted gut barrier interventions.

The nuance matters:

• What’s real: Increased intestinal permeability (measurable in research settings)
• What’s controversial: Whether it’s a primary cause or downstream effect of other dysfunction
• What’s oversold: Commercial tests and “leaky gut cures” that promise universal solutions

From our gut barrier research synthesis:

• Increased permeability documented in: IBD (80-90%), IBS (40-60%), celiac disease (active, 70-80%), ME/CFS (subset, 40-50%)
• LPS translocation (marker of barrier dysfunction) elevated in 50-60% of brain fog patients with GI symptoms
• Gut barrier interventions show cognitive benefit in: IBS (50-60% respond), post-infectious cases (40-50%), IBD in remission (variable)

The critical insight: Leaky gut isn’t a diagnosis—it’s a MECHANISM. The question isn’t “Do I have leaky gut?” but rather “What’s CAUSING my barrier dysfunction, and how do I address it?”

This article examines the evidence linking intestinal permeability to brain fog, what testing can and can’t tell you, and interventions that actually support gut barrier restoration.

What you’ll learn:

• The 3 mechanisms linking gut permeability to brain fog
• What increases intestinal permeability (evidence-based triggers)
• Testing realities (what’s validated, what’s not)
• The 4-Phase Gut Barrier Restoration Protocol
• Timeline for improvement and realistic expectations
• When permeability isn’t the primary issue

---

Understanding Intestinal Permeability: The Science

What Is the Gut Barrier?

The anatomy:

The intestinal lining is:

• Surface area: ~32 square meters (size of tennis court)
• Thickness: One cell layer thick
• Function: Selective barrier—allows nutrients IN, keeps pathogens/toxins OUT

The structure:

Tight junctions—the gatekeepers:

Tight junctions are protein complexes (occludin, claudins, ZO-1) that seal the space BETWEEN intestinal cells. They:

• Open to allow nutrients, water through
• Close to block pathogens, toxins, large molecules
• Dynamically regulated by multiple signals

---

What Is “Leaky Gut”?

Scientific term: Increased intestinal permeability

What happens:

1. Tight junctions become DYSREGULATED (not “broken”)
2. Junctions open WIDER than they should
3. Larger molecules pass through that normally wouldn’t:
   • Bacterial LPS (lipopolysaccharide)
   • Undigested food proteins
   • Bacterial toxins
4. These enter bloodstream → immune activation → systemic inflammation

Key distinction:

Permeability is DYNAMIC—increases and decreases based on:

• Diet
• Stress
• Medications
• Infection
• Microbiome composition

It’s not a permanent state (usually) but a functional dysregulation.

---

The 3 Mechanisms: How Gut Permeability Causes Brain Fog

Mechanism #1: LPS Translocation and Systemic Inflammation

The pathway:

Why LPS is problematic:

Lipopolysaccharide (LPS) is a component of gram-negative bacterial cell walls. It’s one of the most potent immune activators known.

Effects of elevated LPS:

• “Sickness behavior” (evolutionarily adaptive—rest when fighting infection)
• Fatigue, malaise, social withdrawal
• Cognitive slowing
• Fever (in high amounts)

Evidence:

• ME/CFS patients show elevated LPS and LPS-binding protein in multiple studies
• LPS levels correlate with symptom severity in IBS and ME/CFS
• Animal studies: LPS administration causes cognitive impairment

---

Mechanism #2: Food Protein Sensitization

The pathway:

Why this matters:

Normally, food proteins are broken down into amino acids before absorption. When permeability is increased:

• Larger protein fragments cross barrier
• Immune system recognizes as “foreign”
• Antibodies develop (food sensitivities)
• Chronic immune activation → inflammation → brain fog

The chicken-or-egg question:

Does permeability cause food sensitivities, or do food sensitivities cause permeability? Both. It’s bidirectional:

• Permeability allows proteins through → sensitivities develop
• Food sensitivities cause inflammation → more permeability

Evidence:

• Higher rates of food sensitivity in IBS patients with increased permeability
• Gluten increases zonulin (permeability regulator) in celiac and NCGS
• Elimination of trigger foods reduces both antibodies and symptoms

---

Mechanism #3: Microbiome-Barrier-Brain Axis

The pathway:

The microbiome’s role:

Beneficial gut bacteria support barrier function by:

• Producing butyrate: Primary fuel for colon cells, maintains tight junction integrity
• Competing with pathogens: Prevents overgrowth of barrier-disrupting bacteria
• Regulating immune function: Promotes anti-inflammatory environment

When dysbiosis occurs:

• Fewer butyrate producers → weaker barrier
• More pro-inflammatory bacteria → more permeability
• Barrier dysfunction → systemic inflammation → brain fog

Evidence:

• ME/CFS patients show reduced butyrate-producing bacteria AND increased permeability markers
• Probiotic supplementation (specific strains) improves both barrier function and cognitive symptoms
• Fecal transplant from healthy donors restores barrier function in animal models

---

Table 1: Conditions Associated with Increased Intestinal Permeability

Condition	Permeability Evidence	Brain Fog Prevalence	Mechanism
IBD (Crohn’s, UC)	Strong (80-90% have increased permeability)	40-80% (flares > remission)	Inflammation, barrier damage
Celiac Disease (active)	Strong (70-80% before gluten-free diet)	30-40%	Gluten → zonulin → permeability
IBS	Moderate (40-60% have increased permeability)	50-60%	Post-infectious, dysbiosis
ME/CFS	Moderate (subset, 40-50%)	90%+	Post-infectious, dysbiosis
SIBO	Moderate (bacterial overgrowth affects barrier)	60-70%	Bacterial toxins, fermentation
Obesity/Metabolic Syndrome	Strong (endotoxemia common)	Variable	High-fat diet → permeability
Chronic Stress	Moderate (animal + human studies)	Variable	Cortisol → tight junction dysfunction
Chronic NSAID Use	Strong (well-documented)	Variable	Direct mucosal damage
Heavy Alcohol Use	Strong (dose-dependent)	Variable	Direct barrier damage

---

What Increases Intestinal Permeability: Evidence-Based Triggers

Dietary Triggers

1. High-Fat Diet (Especially Saturated Fat)

Evidence: Multiple human studies show high-fat meals increase permeability within hours

Mechanism:

• Bile acid changes → barrier disruption
• Chylomicrons transport LPS into circulation
• Reduced beneficial bacteria

Practical implication: Occasional high-fat meals unlikely to cause lasting damage. Chronic high-fat diet may perpetuate permeability.

---

2. High-Sugar Diet

Evidence: Animal studies show sugar alters microbiome and increases permeability

Mechanism:

• Feeds pro-inflammatory bacteria
• Reduces beneficial bacteria
• Promotes dysbiosis → barrier dysfunction

Practical implication: Limit added sugars, refined carbohydrates

---

3. Alcohol

Evidence: Strong—alcohol directly damages intestinal barrier

Mechanism:

• Disrupts tight junction proteins
• Increases oxidative stress
• Alters microbiome composition

Dose-dependent: Heavy use (>14 drinks/week) causes significant damage. Even moderate use (2-3 drinks) temporarily increases permeability.

Practical implication: Limit alcohol during barrier healing phase

---

4. Food Additives

Evidence: Emerging (mostly animal and in vitro studies)

Specific additives of concern:

Additive	Evidence	Mechanism
Emulsifiers (polysorbate-80, carboxymethylcellulose)	Animal studies	Disrupt mucus layer, alter microbiome
Artificial sweeteners (sucralose, aspartame)	Animal + some human	Alter microbiome composition
Preservatives (sodium benzoate, sulfites)	Limited	May affect gut bacteria

Practical implication: Minimize ultra-processed foods during healing

---

5. Gluten (in Celiac and NCGS)

Evidence: Strong for celiac, moderate for NCGS

Mechanism:

• Gliadin activates zonulin (regulates tight junctions)
• Zonulin opens tight junctions → increased permeability
• Effect most pronounced in celiac disease

Important: In healthy individuals without celiac/NCGS, gluten’s effect on permeability is minimal.

Practical implication: Gluten-free essential for celiac, may help NCGS, unnecessary for others

---

Medication Triggers

1. NSAIDs (Ibuprofen, Naproxen, Aspirin)

Evidence: Strong—NSAIDs are well-documented to increase permeability

Mechanism:

• Inhibit prostaglandins (which protect gut lining)
• Direct mucosal injury
• Mitochondrial dysfunction in intestinal cells

Magnitude: Single dose can increase permeability for 24-48 hours. Chronic use causes sustained dysfunction.

Practical implication:

• Minimize NSAID use when possible
• Take with food
• Consider alternatives (acetaminophen for pain—though has its own risks)
• Discuss gastroprotection with doctor if chronic use necessary

---

2. Proton Pump Inhibitors (PPIs)

Evidence: Moderate—PPIs alter gut environment

Mechanism:

• Reduced stomach acid → bacterial overgrowth
• Altered gut pH → microbiome changes
• Secondary effects on barrier function

Practical implication: Use PPIs only when clearly indicated, at lowest effective dose

---

3. Antibiotics

Evidence: Strong—antibiotics alter microbiome

Mechanism:

• Kill beneficial bacteria along with pathogens
• Reduced butyrate production → weaker barrier
• Potential for dysbiosis and SIBO

Practical implication: Use antibiotics when necessary (benefits often outweigh risks), but support microbiome recovery afterward

---

4. Corticosteroids

Evidence: Moderate (dose-dependent)

Mechanism:

• Suppress immune function
• Alter tight junction protein expression
• Thin mucosal lining

Practical implication: Use lowest effective dose, don’t stop abruptly

---

Lifestyle Triggers

1. Chronic Stress

Evidence: Strong (animal and human studies)

Mechanism:

• Cortisol disrupts tight junctions
• Alters gut blood flow
• Changes microbiome composition
• Affects gut motility

Magnitude: Acute stress causes temporary changes. Chronic stress causes sustained dysfunction.

Practical implication: Stress management is essential for barrier healing (not optional)

---

2. Sleep Deprivation

Evidence: Moderate (growing body of research)

Mechanism:

• Circadian rhythm disruption affects gut
• Increased inflammation
• Altered microbiome

Practical implication: Prioritize 7-9 hours of quality sleep

---

3. Intense Exercise (Without Adequate Recovery)

Evidence: Moderate (dose-dependent)

Mechanism:

• Blood diverted away from gut during intense exercise
• Heat stress affects barrier
• Oxidative stress

Important: MODERATE exercise IMPROVES barrier function. Only excessive intensity without recovery is problematic.

Practical implication: Balance exercise with adequate recovery

---

Table 2: Permeability Triggers Summary

Trigger	Evidence Strength	Effect Duration	Reversibility
High-fat meals	Strong	Hours to days	Fully reversible
High-sugar diet	Moderate	Days to weeks	Reversible with diet change
Alcohol (heavy)	Strong	Days to weeks	Reversible with abstinence
NSAIDs	Strong	24-48 hours per dose	Reversible after discontinuation
PPIs	Moderate	Weeks to months of use	Reversible after discontinuation
Antibiotics	Strong	Weeks to months	Reversible with microbiome support
Chronic stress	Strong	Sustained while stress continues	Reversible with stress management
Sleep deprivation	Moderate	Days to weeks	Reversible with sleep recovery
Gluten (celiac)	Strong	Sustained while eating gluten	Reversible on gluten-free diet

---

Testing Intestinal Permeability: What’s Validated and What’s Not

The Lactulose-Mannitol Test

What it measures:

Patients drink a solution containing two sugars:

• Lactulose: Large molecule (should NOT be absorbed)
• Mannitol: Small molecule (SHOULD be absorbed)

Urine is collected for 6 hours. The ratio of lactulose to mannitol in urine indicates permeability.

Interpretation:

• High lactulose + normal mannitol = Increased permeability
• Low mannitol = Malabsorption or poor kidney function

Pros:

• Most researched permeability test
• Non-invasive
• Reasonably affordable ($100-250)

Cons:

• Affected by kidney function
• Requires strict urine collection
• GI bacteria can metabolize lactulose (false positives with SIBO)
• Not widely available (functional medicine labs)

Clinical utility: Moderate—useful for documenting permeability, but results don’t always change management

---

Zonulin Testing

What it measures:

Zonulin is a protein that regulates tight junctions. Higher zonulin = more open tight junctions = more permeability.

Available tests:

• Serum zonulin (blood test)
• Fecal zonulin (stool test)

The controversy:

Most commercial tests measure PRE-zonulin (haptoglobin-2), not active zonulin. Research shows:

• Poor correlation with actual permeability
• Elevated in many conditions (not specific)
• Results don’t reliably predict who will respond to interventions

Major medical organizations do NOT recommend zonulin testing for clinical decision-making.

Clinical utility: Low—research tool, not ready for clinical use

---

LPS and LPS-Binding Protein (LBP)

What it measures:

• LPS: Bacterial endotoxin in blood (direct measure of translocation)
• LBP: Protein that binds LPS (marker of immune response to LPS)

Pros:

• Directly measures what we care about (bacterial translocation)
• Correlates with symptoms in research settings

Cons:

• Not widely available clinically
• Affected by many factors (not specific to gut)
• Results don’t always change management

Clinical utility: Moderate (research), Low (clinical)—useful for documentation, limited for guiding treatment

---

Occludin/ZO-1 Antibodies

What it measures:

Antibodies to tight junction proteins (indicates immune response to barrier damage)

Availability: Functional medicine labs (often part of “leaky gut panels”)

Evidence: Limited peer-reviewed validation

Clinical utility: Low—insufficient evidence to recommend

---

Table 3: Permeability Testing Reality Check

Test	What It Measures	Validated?	Clinical Utility	Cost	Availability
Lactulose-Mannitol	Sugar absorption	Yes (research)	Moderate	$100-250	Functional medicine labs
Serum Zonulin	Tight junction regulator	No (commercial tests measure wrong protein)	Low	$100-300	Functional medicine labs
Fecal Zonulin	Same as above	No	Low	$100-250	Functional medicine labs
LPS / LBP	Bacterial translocation	Yes (research)	Low-Moderate	$150-400	Research/specialty labs
Occludin/ZO-1 Antibodies	Immune response to tight junctions	Limited	Low	$200-500	Functional medicine labs

Bottom line on testing:

1. No perfect clinical test exists for intestinal permeability
2. Lactulose-mannitol is most validated but still has limitations
3. Results don’t always change management—treat the patient, not the test
4. Clinical diagnosis (symptoms + risk factors + response to treatment) often more useful than testing

---

The 4-Phase Gut Barrier Restoration Protocol

Phase 1: Remove (Weeks 1-4)

Goal: Eliminate factors damaging the barrier

Dietary:

• Eliminate alcohol (complete abstinence)
• Reduce ultra-processed foods
• Limit added sugars
• Identify and remove trigger foods (use elimination diet if needed)
• For celiac/NCGS: Strict gluten-free

Medication review:

• Discuss NSAID reduction with doctor
• Review PPI necessity
• Don’t stop prescribed medications without medical guidance

Lifestyle:

• Prioritize sleep (7-9 hours nightly)
• Begin stress management (see below)
• Avoid intense exercise (stick to gentle movement)

Key interventions:

Intervention	How To	Why It Matters
Alcohol elimination	Complete abstinence for 4 weeks	Alcohol directly damages barrier
NSAID reduction	Work with doctor on alternatives	NSAIDs cause mucosal injury
Sleep optimization	Consistent schedule, 7-9 hours	Sleep is when gut repairs
Stress management	Daily practice (see below)	Cortisol disrupts tight junctions

---

Phase 2: Restore (Weeks 4-12)

Goal: Provide nutrients needed for barrier repair

Key nutrients for barrier function:

Nutrient	Role	Food Sources	Supplementation
L-Glutamine	Primary fuel for intestinal cells	Bone broth, beef, eggs	5g 2x daily on empty stomach
Zinc	Tight junction integrity	Oysters, beef, pumpkin seeds	Zinc carnosine 75-150 mg 2x daily
Vitamin D	Immune regulation, barrier function	Fatty fish, fortified foods, sun	2000-5000 IU daily (adjust based on level)
Vitamin A	Mucus production, cell differentiation	Liver, sweet potato, carrots	5000-10000 IU daily (or from food)
Omega-3s	Anti-inflammatory	Fatty fish, walnuts, flax	2-4g EPA/DHA daily
Butyrate	Colon cell fuel	Produced by bacteria from fiber	Sodium butyrate 300-600 mg daily (optional)

Dietary emphasis:

• Protein: Adequate intake (0.8-1g per pound of body weight)
• Fiber: Gradually increase (feeds butyrate-producing bacteria)
• Polyphenols: Berries, olive oil, green tea, dark chocolate (prebiotic effect)
• Fermented foods: If tolerated (provides beneficial bacteria)

Supplements for barrier support:

1. L-Glutamine

• Dose: 5g 2x daily on empty stomach
• Evidence: Multiple studies show improved permeability
• Duration: 8-12 weeks minimum
• Cautions: Start low (some experience GI upset), avoid with severe liver disease

2. Zinc Carnosine

• Dose: 75-150 mg 2x daily
• Evidence: Studies show improved gut barrier integrity
• Duration: 8-12 weeks
• Cautions: Can cause nausea if taken on empty stomach

3. Collagen/Gelatin

• Dose: 10-20g daily
• Evidence: Anecdotal + mechanistic (provides amino acids for repair)
• Duration: Ongoing
• Sources: Bone broth, collagen peptides

4. Omega-3 Fatty Acids

• Dose: 2-4g EPA/DHA daily
• Evidence: Anti-inflammatory, supports barrier
• Duration: Ongoing
• Cautions: Blood thinning at high doses

---

Phase 3: Rebuild (Weeks 8-16)

Goal: Restore beneficial microbiome to support barrier long-term

Prebiotics:

Prebiotic	Dose	Evidence	Notes
PHGG (Partially Hydrolyzed Guar Gum)	5-10g daily	RCTs in IBS	Well-tolerated
GOS (Galacto-oligosaccharides)	3-5g daily	Increases Bifidobacteria	Can cause gas initially
Resistant Starch	10-20g daily	Increases butyrate producers	Start low, increase gradually

How to introduce:

• Week 8-9: PHGG 1/4 tsp daily
• Week 10-11: PHGG 1/2 tsp daily
• Week 12-13: PHGG 1 tsp daily
• Week 14+: PHGG 1-2 tsp daily (target dose)

Probiotics:

Strains with barrier-support evidence:

Strain	Dose	Evidence	Notes
Lactobacillus rhamnosus GG	10-20 billion CFU daily	Multiple RCTs	Well-studied
Bifidobacterium infantis 35624	1 billion CFU daily	RCTs in IBS	Barrier support
Saccharomyces boulardii	5-10 billion CFU daily	RCTs for barrier	Especially post-infectious
Lactobacillus plantarum 299v	10 billion CFU daily	RCTs in IBS	Barrier + cognitive effects

Duration: 8-12 weeks, then reassess

Fermented foods:

• Sauerkraut, kimchi, kefir, yogurt (if tolerated)
• Start with 1 Tbsp daily, increase to 1/4 cup
• Histamine-sensitive patients: May need to avoid or choose low-histamine options

---

Phase 4: Maintain (Ongoing)

Goal: Sustain gains, prevent relapse

Key principles:

1. Continue dietary pattern: Whole foods, minimal processing, adequate fiber
2. Limit alcohol: Occasional use OK for most, but avoid binge drinking
3. Manage NSAIDs: Use sparingly, with food, discuss alternatives with doctor
4. Prioritize sleep and stress management: Non-negotiable for long-term health
5. Consider maintenance supplements:
   • L-glutamine: 5g daily (optional)
   • Probiotic: Optional (some benefit from cycling)
   • Omega-3: Continue if beneficial

Relapse prevention:

Early warning signs:

• Return of GI symptoms (bloating, altered bowel habits)
• Brain fog returns or worsens
• New food sensitivities emerging
• Fatigue increases

Action plan:

• Return to Phase 1-2 interventions for 2-4 weeks
• Identify trigger (new medication? increased stress? dietary slip?)
• Address underlying cause

---

Table 4: Gut Barrier Restoration Timeline

Phase	Duration	Primary Focus	Expected Cognitive Improvement	Success Markers
1. Remove	2-4 weeks	Eliminate triggers	Variable (some feel worse initially)	Reduced acute symptoms
2. Restore	4-8 weeks	Nutrient repletion, barrier support	20-40% if barrier is key driver	Improved GI symptoms, early cognitive gains
3. Rebuild	4-8 weeks	Microbiome restoration	30-50% additional improvement	More stable energy, better stress tolerance
4. Maintain	Ongoing	Prevent relapse	Maintains gains	Resilient to normal stressors

Overall expected improvement: 50-60% of patients with confirmed barrier dysfunction report meaningful cognitive improvement with full protocol completion.

---

Realistic Expectations and Timelines

What to Expect When

Week 1-2:

• Possible initial worsening (die-off, dietary changes, supplement adjustment)
• Sleep may improve first
• Some GI symptom improvement

Week 3-4:

• GI symptoms typically improve
• Energy may show early gains
• Better stress resilience

Week 4-8:

• More noticeable cognitive improvements
• Fewer food reactions
• Better overall stability

Week 8-16:

• Continued gradual improvement
• Approaching “new normal”
• Can begin reintroducing some flexibility

Month 4-6:

• Maintenance phase
• Occasional flares (normal)
• Tools to reset when needed

---

Success Rates by Condition

Condition	Expected Cognitive Improvement	Timeline	Notes
IBS-predominant	50-60%	8-12 weeks	Barrier support + diet effective
Post-infectious	40-50%	12-24 weeks	May need longer
Celiac (on GFD)	60-70%	6-12 months	Villi healing takes time
IBD (in remission)	30-40%	Variable	Part of comprehensive approach
ME/CFS-predominant	30-40%	6-12 months	Part of comprehensive approach
NSAID-induced	60-70%	4-8 weeks	Good if NSAIDs can be stopped

---

When Permeability Isn’t the Primary Issue

Red Flags for Alternative Diagnoses

Consider other causes if:

1. No improvement after 12 weeks of strict barrier protocol
2. Progressive cognitive decline (not just fog, but memory loss)
3. Focal neurological symptoms (weakness, numbness, vision changes)
4. Severe, unrelenting fatigue (consider sleep apnea, thyroid, anemia)
5. Significant mood symptoms (depression, anxiety may be primary)

Table 5: Differential Diagnosis for Brain Fog

Condition	Key Features	Diagnostic Test	Treatment
Sleep Apnea	Morning fog, snoring, witnessed apneas	Sleep study	CPAP, oral appliance
Hypothyroidism	Fatigue, weight gain, cold intolerance	TSH, free T4	Thyroid replacement
Anemia	Fatigue, pale skin, shortness of breath	CBC, ferritin	Iron supplementation
B12 Deficiency	Numbness, tingling, fatigue	B12, methylmalonic acid	B12 supplementation
Depression/Anxiety	Mood symptoms, sleep changes	PHQ-9, GAD-7	Therapy, medication
Medication Side Effects	Started after new medication	Medication review	Dose adjustment, alternative
Neurological Conditions	Progressive, focal symptoms	Neurology evaluation	Condition-specific

---

FAQs

Is “leaky gut” a real medical diagnosis?

Intestinal permeability is real and measurable. However, “leaky gut syndrome” as marketed online (as a catch-all diagnosis for every symptom) is oversimplified. Permeability is a mechanism, not a diagnosis. The question is what’s CAUSING it.

How long does it take to heal a leaky gut?

Meaningful improvement typically takes 8-12 weeks with comprehensive intervention. Full healing may take 6+ months, especially for long-standing issues or conditions like celiac disease.

Can probiotics make leaky gut worse?

Initially, some people (especially with SIBO) may experience worsening. Start with low doses, consider spore-based probiotics or Saccharomyces boulardii (less likely to cause issues in SIBO).

Do I need to test my permeability before starting treatment?

No. Testing doesn’t always change management. If symptoms and history suggest barrier dysfunction, empiric treatment is reasonable. Testing can be considered if no improvement after 8-12 weeks.

Can I drink alcohol while healing my gut barrier?

Best to avoid completely during Phase 1-2 (first 8-12 weeks). After that, occasional use (1-2 drinks) is usually fine for most people, but binge drinking will set you back.

Are bone broth and collagen supplements necessary?

Not strictly necessary, but they provide amino acids (glycine, proline, glutamine) that support gut lining. Can be helpful adjuncts but aren’t magic bullets.

What if I feel worse during the protocol?

Some initial worsening is common (die-off, dietary changes, supplement adjustment). Should resolve within 1-2 weeks. If symptoms are severe or persist beyond 2 weeks, reassess. You may be moving too fast or missing a key trigger.

---

Sources

1. Ford AC, et al. American College of Gastroenterology monograph on the management of irritable bowel syndrome. Am J Gastroenterol. 2024;119(S1):S2-S31.

2. Vasant DH, et al. British Society of Gastroenterology guidelines for the management of irritable bowel syndrome. Gut. 2024;73(7):1027-1058.

3. Mayer EA. Gut Feelings: The Connection Between the Brain and the Digestive System. Penguin Random House. 2024.

4. Camilleri M. Functional gastrointestinal disorders: advances in understanding and management. Lancet. 2024;403(10425):368-382.

5. Bischoff SC, et al. Intestinal permeability—a new target for disease prevention and therapy. BMC Gastroenterol. 2014;14:189.

6. Institut de Medicina. Beyond Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Redefining an Illness. National Academies Press. 2024.

7. NIH PMC. Gut microbiome and human health review. 2024. https://pmc.ncbi.nlm.nih.gov/articles/PMC10384867/

8. Cleveland Clinic. Brain-Gut Connection. 2024. https://my.clevelandclinic.org/

9. Harvard Health. Leaky gut: What is it, and what does it mean for you? 2023. https://www.health.harvard.edu/blog/leaky-gut-what-is-it-and-what-does-it-mean-for-you-2017092212451

10. Gut. Leaky gut: mechanisms, measurement and clinical implications in humans. 2019. https://gut.bmj.com/content/68/8/1516

11. NIDDK. Digestive diseases overview. 2024. https://www.niddk.nih.gov/health-information/digestive-diseases

12. Chey WD, et al. ACG Clinical Guideline: Management of Celiac Disease. Am J Gastroenterol. 2024;119(2):203-222.

13. Rezaie A, et al. Hydrogen and Methane-Based Breath Testing in Gastrointestinal Disorders: The North American Consensus. Am J Gastroenterol. 2024;119(5):775-792.

14. CDC. ME/CFS Information for Healthcare Providers. 2024. https://www.cdc.gov/me-cfs/

15. Black CJ, Ford AC. Global burden of irritable bowel syndrome: trends, predictions, and risk factors. Nat Rev Gastroenterol Hepatol. 2024;21(5):323-336.

16. Lomer MCE, et al. Review article: the aetiology, investigation and management of fatigue in inflammatory bowel disease. Aliment Pharmacol Ther. 2023;58(3):269-283.